U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889844) titled 'Observational Cross-reactivity Study for Colorectal Cancer Diagnosis' on March 17.
Brief Summary: The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is
Does the blood test have a low false positive rate in the main study population?
Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
Study Start Da...